Psyence Biomedical Ltd. (PBMWW) stock
PBMWWNasdaqPharmaceutical PreparationsFiscal year ends March 31Also trades as PBM
$0.01−0.00 (-2.50%)
Close on Oct 30, 2026Market cap –P/E –Yield –
Psyence Biomedical free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2026 it was -$8.14M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$8.14M | – |
| FY2025 | Mar 31, 2025 | -$3.74M | – |
| FY2024 | Mar 31, 2024 | -$2.95M | – |